Korea Cell-based Artificial Blood Project Group Medicine Promotion Foundation,as an affiliated organization
of the head of this project group, supports the operation and administrative personnel of this project group.Based on our experience,
we have secured a technology commercialization coaching platform in the field of advanced regenerative medicine and carried out support projects.
We support the establishment of a cooperative network to establish a global hub base.

• 01The Cell-based Artificial Blood Technology Development Project Group is a project in cooperation with the Ministry of Health and Welfare, the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Korea Disease Control and Prevention Agency, and the Ministry of Food and Drug Safety to secure the original technology for artificial blood production in response to the blood shortage problem.
• 02This project is expected to overcome the limitations of the existing blood supply system in a situation where blood donations are decreasing due to the declining birthrate and aging population, and to solve problems such as blood safety accidents, short preservation period of transfused blood, and difficulties in supplying rare blood that occurred during the blood donation process.
• 03This project is the first phase ('23~'27) of the third phase of the project (15 years in total), with the goal of 'producing artificial blood for clinical research' for 5 years, 'supporting clinical research and clinical trials of artificial blood' in the second stage ('28~'32), and 'practical use of artificial blood for blood transfusion' in the third stage ('28~'32).

Targetclinical cell-based artificial blood production · Securing manufacturing technology and putting artificial blood into practical use

• 2023
• 2027
• 2032
• 2037

• Step 01

  Multi-ministry joint
  planning R&D

  

  Clinical Artificial Blood production

  Strategy 1.
  Securing artificial blood production technology

  Development of artificial blood cell differentiation and proliferation technology

  R&D and demonstration support for clinical artificial blood

• Step 02

  Clinical Research
  Funding

  

  Clinical Research · examination support

  Strategy 2.
  Establishment of artificial blood manufacturing process platform

  Development of standardized process technology

  Development of quality control suitable for the characteristics of artificial blood

• Step 03

  Promotion of Yetta commercialization

  

  Practical use of artificial blood for blood transfusion

  Strategy 3.
  Evaluation criteria and support for entry into clinical research

  Safety of artificial blood products · Development of efficacy methods

  Preparation of clinical trials and clinical research guidelines